AH Partridge

956 total citations
30 papers, 754 citations indexed

About

AH Partridge is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, AH Partridge has authored 30 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 9 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in AH Partridge's work include Cancer Risks and Factors (11 papers), Breast Cancer Treatment Studies (8 papers) and Reproductive Biology and Fertility (4 papers). AH Partridge is often cited by papers focused on Cancer Risks and Factors (11 papers), Breast Cancer Treatment Studies (8 papers) and Reproductive Biology and Fertility (4 papers). AH Partridge collaborates with scholars based in United States, Switzerland and Italy. AH Partridge's co-authors include E. Mayer, Kathryn J. Ruddy, Carolyn M. Kaelin, E. Claire Dees, John D. Weeks, Mehra Golshan, Jennifer A. Ligibel, Emily Blood, Janet S. de Moor and Karen M. Emmons and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Annals of Oncology.

In The Last Decade

AH Partridge

27 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
AH Partridge United States 6 307 264 186 143 103 30 754
Volker Ziller Germany 17 421 1.4× 239 0.9× 200 1.1× 78 0.5× 65 0.6× 55 1.1k
Melissa Accordino United States 18 445 1.4× 91 0.3× 77 0.4× 112 0.8× 222 2.2× 98 905
E. Mayer United States 3 109 0.4× 258 1.0× 159 0.9× 27 0.2× 58 0.6× 5 498
A.M. Thompson United Kingdom 11 223 0.7× 136 0.5× 51 0.3× 123 0.9× 110 1.1× 24 552
Ioannis Kyvernitakis Germany 19 467 1.5× 107 0.4× 128 0.7× 46 0.3× 81 0.8× 70 1.1k
Monika Sztankay Austria 16 395 1.3× 37 0.1× 149 0.8× 22 0.2× 121 1.2× 50 648
Anna Moseley United States 11 286 0.9× 34 0.1× 54 0.3× 53 0.4× 66 0.6× 34 606
Jean‐François Baladi United States 18 69 0.2× 95 0.4× 241 1.3× 33 0.2× 126 1.2× 29 1.1k
Lindsey Hageman United States 13 216 0.7× 82 0.3× 739 4.0× 21 0.1× 41 0.4× 75 1.2k
Ellen G. Engelhardt Netherlands 15 260 0.8× 19 0.1× 38 0.2× 182 1.3× 133 1.3× 43 749

Countries citing papers authored by AH Partridge

Since Specialization
Citations

This map shows the geographic impact of AH Partridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AH Partridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AH Partridge more than expected).

Fields of papers citing papers by AH Partridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AH Partridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AH Partridge. The network helps show where AH Partridge may publish in the future.

Co-authorship network of co-authors of AH Partridge

This figure shows the co-authorship network connecting the top 25 collaborators of AH Partridge. A scholar is included among the top collaborators of AH Partridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AH Partridge. AH Partridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niman, Samuel M., Marco Ruggeri, Fedro A. Peccatori, et al.. (2025). LBA12 5-year follow-up results from the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial. Annals of Oncology. 36. S1557–S1557.
2.
Demeestere, Isabelle, Samuel M. Niman, AH Partridge, et al.. (2025). 415O Predictive factors of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in the POSITIVE trial. ESMO Open. 10. 104987–104987. 1 indexed citations
3.
Niman, Samuel M., AH Partridge, Marco Ruggeri, et al.. (2024). 1814O Breastfeeding in women with hormone receptor-positive breast cancer who conceived after temporary interruption of endocrine therapy: Results from the POSITIVE trial. Annals of Oncology. 35. S1076–S1076. 3 indexed citations
4.
O’Neill, Anne, et al.. (2019). Abstract GS6-05: The impact of breast cancer surgery on quality of life: Long term results from E5103. Cancer Research. 79(4_Supplement). GS6–5. 2 indexed citations
5.
6.
Tamimi, RM, et al.. (2019). Abstract GS6-06: Local therapy and quality of life outcomes in young women with breast cancer. Cancer Research. 79(4_Supplement). GS6–6. 3 indexed citations
7.
8.
9.
Lambertini, Matteo, Massimo Di Maïo, Olivia Pagani, et al.. (2018). The BCY3/BCC 2017 survey on physicians’ knowledge, attitudes and practice towards fertility and pregnancy issues in young breast cancer patients. European Journal of Cancer. 92. S22–S22.
10.
Gelber, Shari, et al.. (2017). Abstract P2-09-07: Drugs don't work if people don't take them: Non-initiation of endocrine therapy in young women. Cancer Research. 77(4_Supplement). P2–9. 3 indexed citations
11.
Lambertini, Matteo, Massimo Di Maïo, Olivia Pagani, et al.. (2017). A survey on physicians’ knowledge, practice and attitudes on fertility and pregnancy issues in young breast cancer patients. The Breast. 32. S85–S86. 6 indexed citations
12.
13.
Tolaney, SM, DA Yardley, Beverly Moy, et al.. (2013). Abstract S1-04: A phase II study of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC). Cancer Research. 73(24_Supplement). S1–4. 22 indexed citations
14.
15.
Sepucha, Karen, J Hirshfield-Bartek, Susan L. Troyan, et al.. (2011). P4-11-10: Perceptions, Knowledge and Satisfaction with Contralateral Prophylactic Mastectomy among Young Women with Breast Cancer.. Cancer Research. 71(24_Supplement). P4–11. 2 indexed citations
16.
Partridge, AH, et al.. (2010). Abstract P4-09-12: The Effect of Age on Breast Cancer Outcomes in Women with Her-2 Positive Breast Cancer: Results from the HERA Trial. Cancer Research. 70(24_Supplement). P4–9. 3 indexed citations
17.
18.
Ruddy, Kathryn J., E. Mayer, & AH Partridge. (2009). Patient adherence and persistence with oral anticancer treatment. CA A Cancer Journal for Clinicians. 59(1). 56–66. 466 indexed citations
19.
Partridge, AH, Emily Blood, E. Claire Dees, et al.. (2008). Risk Perceptions and Psychosocial Outcomes of Women With Ductal Carcinoma In Situ: Longitudinal Results From a Cohort Study. JNCI Journal of the National Cancer Institute. 100(4). 243–251. 140 indexed citations
20.
Gelber, Shari, et al.. (2006). Menopausal-type symptoms in young breast cancer survivors. Annals of Oncology. 17(12). 1777–1782. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Volker Ziller Breakdown of academic impact, for papers by Melissa Accordino Breakdown of academic impact, for papers by E. Mayer Breakdown of academic impact, for papers by A.M. Thompson Breakdown of academic impact, for papers by Ioannis Kyvernitakis Breakdown of academic impact, for papers by Monika Sztankay Breakdown of academic impact, for papers by Anna Moseley Breakdown of academic impact, for papers by Jean‐François Baladi Breakdown of academic impact, for papers by Lindsey Hageman Breakdown of academic impact, for papers by Ellen G. Engelhardt
Rankless by CCL
2026